competitively inhibiting 11 𝛽-HSD 1, thereby promoting the production of 7 𝛽-OH-DHEA instead of active glucocorticoids.
This action might counteract the glucocorticoids' effect of reducing uncoupling proteins—proteins that allow protons to flow into the mitochondrial matrix without generating ATP, thus converting energy into heat and enhancing thermogenesis.
Additionally, 7-Keto-DHEA could directly increase the levels of these uncoupling proteins, further supporting its role in promoting thermogenesis. [4.]
7-Keto DHEA has shown significant effects as an immune modulator in the context of HIV and tuberculosis (TB) co-infection.
Research indicates that 7-Keto DHEA enhances Th1 immune responses, crucial for fighting TB. In studies, 7-Keto DHEA treatment improved the function of CD4+ T cells by increasing their proliferation and boosting the production of key cytokines like IFN-γ and TNF-α, which are vital for controlling mycobacterial infection.
Furthermore, 7-Keto DHEA shifted the immune response by reducing the proportion of regulatory T cells and increasing the Th1 cells, which are associated with better disease outcomes in TB.
This adjustment in immune cell dynamics suggests that 7-Keto DHEA could serve as a beneficial adjunct therapy in managing TB, particularly in individuals co-infected with HIV, by reinforcing the body's response to infection.
Understanding the clinical applications of 7-Keto DHEA is essential for assessing its potential therapeutic value in various health conditions.
One of the most widely studied clinical applications of 7-Keto DHEA is its role in weight management. Research suggests that supplementation with 7-Keto DHEA may promote weight loss by increasing metabolic rate and thermogenesis, leading to enhanced calorie expenditure.
Research indicated that optimal weight loss results without a decrease in metabolic rate occur in conjunction with exercise and calorie restriction, particularly in overweight or obese individuals. [6.]
However, other studies do not show the same benefits. [5.] While further research is needed to confirm these findings and elucidate the mechanisms underlying its effects on weight, 7-Keto DHEA may be a potential adjunctive therapy for obesity management in conjunction with diet and exercise.
7-Keto DHEA has shown promising effects in enhancing memory, particularly in reversing memory deficits induced by the anticholinergic agent scopolamine in animal models.
In experiments using young mice, a single dose of 24 mg/kg of 7-Keto DHEA-acetate completely reversed memory impairment caused by scopolamine, showcasing a more potent effect compared to DHEA itself.
These findings suggest that 7-Keto DHEA could be a valuable agent for investigating human memory enhancement, particularly because it does not convert to sex hormones and thus avoids the hormonal side effects associated with DHEA.
In a study on post-traumatic stress disorder (PTSD), benefits were observed when patients received 7-keto DHEA at doses ranging from 25 to 150 mg per day. This treatment, given in an open-label trial, was effective for those with PTSD who had resisted multiple previous treatments.
The choice of 7-keto DHEA over DHEA was due to its non-aromatizable nature and potentially superior anti-glucocorticoid properties. This form of DHEA provided rapid, noticeable improvements in PTSD symptoms, suggesting its potential for larger, more rigorous clinical trials.
7-Keto DHEA seems to be safe when used appropriately. Doses of up to 200 mg/day have been well-tolerated in healthy males for up to 4 weeks. [2.] However, it is essential to monitor for side effects and discontinue use if they occur or consult a healthcare professional for guidance.
7-Keto DHEA levels can be assessed in saliva or blood. Blood testing requires a blood draw via venipuncture.
Salivary testing may be done from the comfort of home or in a clinical setting.
It is important to note that supplementing with 7-keto DHEA will raise supplement levels in saliva, resulting in a high 7-Keto DHEA/DHEA ratio, without raising the levels of androgens or estrogen. [10.]
In contrast, supplementation with DHEA will also raise levels of androgens and estrogen.
It is important to consult with the laboratory company used for testing 7-keto DHEA levels. Optimal ranges for salivary 7-Keto DHEA have been given as: [10.]
41-130 pg/mL
Low levels of 7-Keto DHEA may correlate with low levels of DHEA, which naturally declines in production with age. This can manifest as difficulty with weight loss, memory problems, and other symptoms of low hormones such as low libido. Low levels of 7-Keto DHEA, especially in the setting of symptoms of hormone deficiency, may warrant additional assessment of hormones such as estrogen, testosterone, and DHEA.
High levels of 7-Keto DHEA most commonly occur in the setting of excessive supplementation with DHEA or 7-Keto DHEA. With 7-Keto DHEA supplementation, only increases in 7-Keto DHEA are seen. [10.]
In contrast, supplementation with DHEA may also raise levels of androgens and estrogen. [10.]
[1.] Bobyleva V, Kneer N, Bellei M, Battelli D, Lardy HA. Concerning the mechanism of increased thermogenesis in rats treated with dehydroepiandrosterone. J Bioenerg Biomembr. 1993 Jun;25(3):313-21. doi: 10.1007/BF00762592. PMID: 8349575.
[2.] Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, Lardy H. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers. Clin Invest Med. 2000 Oct;23(5):300-10. PMID: 11055323.
[3.] Hennebert O, Chalbot S, Alran S, Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007 May;104(3-5):326-33. doi: 10.1016/j.jsbmb.2007.03.026. Epub 2007 Mar 24. PMID: 17467270.
[4.] Ihler G, Chami-Stemmann H. 7-oxo-DHEA and Raynaud's phenomenon. Med Hypotheses. 2003 Mar;60(3):391-7. doi: 10.1016/s0306-9877(02)00409-7. PMID: 12581618.
[5.] Jeyaprakash N, Maeder S, Janka H, Stute P. A systematic review of the impact of 7-keto-DHEA on body weight. Arch Gynecol Obstet. 2023 Sep;308(3):777-785. doi: 10.1007/s00404-022-06884-8. Epub 2022 Dec 25. PMID: 36566478; PMCID: PMC10348924.
[6.] Kaiman DS, Colker CM, Swain M, Torina GC, Shi Q. A randomized, double-blind, placebo-controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults. Current Therapeutic Research-clinical and Experimental. 2000;61(7):435-442. doi:https://doi.org/10.1016/s0011-393x(00)80026-0